此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Persona Ti-Nidium 上市后临床跟进 (TKA)

2026年9月16日 更新者:Zimmer Biomet

Persona® Ti-Nidium® 个性化全膝关节系统 一项使用 Persona Ti-Nidium 全膝关节系统和仪器提供安全性、性能和临床益处数据的上市后临床随访研究

The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.

研究概览

详细说明

The study design is a prospective, multicenter data collection model of the 510(k) cleared Persona Ti-Nidium Total Knee System. The study will require each site to obtain institutional review board (IRB) approval prior to study enrollment. All potential study subjects will be required to participate in the Informed Consent Process.

All study subjects will undergo preoperative clinical evaluations prior to their total knee arthroplasty. Investigators will collect clinical data for a required 10 years. Follow-up clinical visits include Early Post-op, 6 months, 1 year, 2, 3, 5, 7 and 10 years post-operatively.

The objective of this study is to evaluate clinical performance, benefits and safety of the Persona Ti-Nidium implant in total knee arthroplasty.

Specific assessments include:

  1. Confirming the long-term safety, performance and clinical benefits of the Persona Ti-Nidium total knee system and instrumentation in primary and revision TKA.
  2. Verifying that, under normal use, the performance and clinical benefits of this device and its instrumentation conform to those intended by the manufacturer by recording patient-reported clinical outcomes measures (PROMs) and radiographic outcomes (if available).

研究类型

介入性

注册 (估计的)

240

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Colorado
      • Parker、Colorado、美国、80134
        • Denver Hip & Knee, Inc.
    • Maryland
      • Hyattsville、Maryland、美国、20782
        • MedStar Health Research Institute
    • Mississippi
      • Jackson、Mississippi、美国、39202
        • Mississippi Sports Medicine and Orthopaedic Center
    • New Mexico
      • Albuquerque、New Mexico、美国、87110
        • New Mexico Orthopaedic Associates
    • North Carolina
      • Durham、North Carolina、美国、27708
        • Duke University
    • Pennsylvania
      • Philadelphia、Pennsylvania、美国、19107
        • Rothman Orthopaedic Institute
    • South Dakota
      • Rapid City、South Dakota、美国、57701
        • Monument Health Rapid City Hospital, Inc.

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Patient is of legal age and skeletally mature
  2. Patient is willing and able to provide written Informed Consent by signing and dating the IRB-approved Informed Consent document
  3. Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol
  4. Patient qualifies for total knee arthroplasty based upon physical exam and medical history, and meets the approved indications for use of the Persona Ti-Nidium Knee System and Vivacit-E polyethylene articulating surface
  5. Independent of study participation, patient is a candidate for the commercially available Persona Ti-Nidium Knee and Vivacit-E polyethylene articulating surface, implanted in accordance with product labeling

Study Device Inclusion Criteria:

The Persona Ti-Nidium Total Knee is intended for patients with severe pain and disability due to the following:

  1. Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
  2. Collagen disorders, and/or avascular necrosis of the femoral condyle.
  3. Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy.
  4. Moderate valgus, varus, or flexion deformities.

Exclusion Criteria:

  1. Patient is unwilling to sign the Informed Consent
  2. Patient is currently participating in any other surgical intervention or pain management study
  3. Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent)
  4. Patient has a mental or neurologic condition who is unwilling or incapable of following postoperative care instructions
  5. Patient has a condition which would, in the judgement of the Investigator, place the patient at undue risk or interfere with the conduct of the study
  6. Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation

Study Device Exclusion Criteria

  1. Previous history of infection in the affected joint and/or other local/systematic infection that may affect the prosthetic joint
  2. Insufficient bone stock on femoral or tibial surfaces
  3. Skeletal immaturity
  4. Neuropathic arthropathy
  5. Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb
  6. A stable, painless arthrodesis in a satisfactory functional position
  7. Severe instability secondary to the absence of collateral ligament integrity
  8. Rheumatoid arthritis (RA) accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin
  9. The kinematic alignment surgical technique is contraindicated for patients with greater than 5° valgus deformity with medial collateral ligament (MCL) insufficiency

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
其他:Persona Ti-Nidium

Primary total knee arthroplasty subjects that receive the Zimmer Biomet Persona Ti-Nidium Total Knee System

Primary Knee Total Arthroplasty

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Oxford Knee Score (OKS)
大体时间:10 years

A patient reported functional outcome score for knee arthroplasty. This score ranges from 0-48, with higher scores indicating a better outcome.

10 years

次要结果测量

结果测量
措施说明
大体时间
Knee Society Score (KSS) Expectations (pre and post op)
大体时间:10 years

This is a 3 question form regarding a patient's expectations of the total knee replacement. The pre-op form assesses the patient's expectations of the knee replacement, and the post-op form addresses how the replacement is meeting said expectations. The score ranges from 3-15, with higher scores indicating a better outcome.

10 years
EuroQol Five Dimension Five Level (EQ-5D-5L) Outcomes Measure
大体时间:10 years

A questionnaire completed by the patient and assesses his/her general health status. This score ranges from -0.573 to 1, with higher recorded scores indicating better overall health.

10 years

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

调查人员

  • 研究主任:Hillary Overholser、Zimmer Biomet Assoc Director

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2021年6月1日

初级完成 (估计的)

2034年5月1日

研究完成 (估计的)

2034年5月1日

研究注册日期

首次提交

2021年3月23日

首先提交符合 QC 标准的

2021年3月23日

首次发布 (实际的)

2021年3月26日

研究记录更新

最后更新发布 (实际的)

2026年9月22日

上次提交的符合 QC 标准的更新

2026年9月16日

最后验证

2025年10月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅